Osimertinib therapy as first-line treatment before acquiring T790M mutation: from AURA1 trial.

Osimertinib therapy as first-line treatment before acquiring T790M mutation: from AURA1 trial. J Thorac Dis. 2018 Sep;10(Suppl 26):S3071-S3077 Authors: Ito K, Hataji O PMID: 30430025 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30430025?dopt=Abstract

Source: Journal of Thoracic Disease - November 16, 2018 Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research

More News: Respiratory Medicine